Oryzon Genomics (Spain) Volatility
ORY Stock | EUR 1.54 0.02 1.28% |
Oryzon Genomics SA maintains Sharpe Ratio (i.e., Efficiency) of -0.14, which implies the firm had a -0.14% return per unit of risk over the last 3 months. Oryzon Genomics SA exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oryzon Genomics' Variance of 2.26, coefficient of variation of (824.80), and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. Key indicators related to Oryzon Genomics' volatility include:
690 Days Market Risk | Chance Of Distress | 690 Days Economic Sensitivity |
Oryzon Genomics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Oryzon daily returns, and it is calculated using variance and standard deviation. We also use Oryzon's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Oryzon Genomics volatility.
Oryzon |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Oryzon Genomics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Oryzon Genomics at lower prices to lower their average cost per share. Similarly, when the prices of Oryzon Genomics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with Oryzon Stock
0.78 | EIDF | Energa Innovacin y | PairCorr |
0.73 | DIA | Distribuidora Internacional | PairCorr |
0.79 | YFID | Fidere Patrimonio SOCIMI | PairCorr |
0.87 | MIO | Media Investment Opt | PairCorr |
Moving against Oryzon Stock
0.83 | PRO | Proeduca Altus SA | PairCorr |
0.73 | SEC | Secuoya Grupo de | PairCorr |
0.67 | AIR | Airbus Group SE | PairCorr |
0.52 | HLZ | Holaluz Clidom SA | PairCorr |
Oryzon Genomics Market Sensitivity And Downside Risk
Oryzon Genomics' beta coefficient measures the volatility of Oryzon stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Oryzon stock's returns against your selected market. In other words, Oryzon Genomics's beta of 0.22 provides an investor with an approximation of how much risk Oryzon Genomics stock can potentially add to one of your existing portfolios. Oryzon Genomics SA exhibits very low volatility with skewness of 1.14 and kurtosis of 3.39. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Oryzon Genomics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Oryzon Genomics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Oryzon Genomics SA Demand TrendCheck current 90 days Oryzon Genomics correlation with market (Dow Jones Industrial)Oryzon Beta |
Oryzon standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 1.5 |
It is essential to understand the difference between upside risk (as represented by Oryzon Genomics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Oryzon Genomics' daily returns or price. Since the actual investment returns on holding a position in oryzon stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Oryzon Genomics.
Oryzon Genomics SA Stock Volatility Analysis
Volatility refers to the frequency at which Oryzon Genomics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Oryzon Genomics' price changes. Investors will then calculate the volatility of Oryzon Genomics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Oryzon Genomics' volatility:
Historical Volatility
This type of stock volatility measures Oryzon Genomics' fluctuations based on previous trends. It's commonly used to predict Oryzon Genomics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Oryzon Genomics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Oryzon Genomics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Oryzon Genomics SA Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Oryzon Genomics Projected Return Density Against Market
Assuming the 90 days trading horizon Oryzon Genomics has a beta of 0.217 . This indicates as returns on the market go up, Oryzon Genomics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Oryzon Genomics SA will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Oryzon Genomics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Oryzon Genomics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Oryzon stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Oryzon Genomics SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
Returns |
What Drives an Oryzon Genomics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Oryzon Genomics Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Oryzon Genomics is -707.66. The daily returns are distributed with a variance of 2.24 and standard deviation of 1.5. The mean deviation of Oryzon Genomics SA is currently at 1.03. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | 0.22 | |
σ | Overall volatility | 1.50 | |
Ir | Information ratio | -0.21 |
Oryzon Genomics Stock Return Volatility
Oryzon Genomics historical daily return volatility represents how much of Oryzon Genomics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm assumes 1.4976% volatility of returns over the 90 days investment horizon. By contrast, Dow Jones Industrial accepts 0.7736% volatility on return distribution over the 90 days horizon. Performance |
Timeline |
About Oryzon Genomics Volatility
Volatility is a rate at which the price of Oryzon Genomics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Oryzon Genomics may increase or decrease. In other words, similar to Oryzon's beta indicator, it measures the risk of Oryzon Genomics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Oryzon Genomics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Oryzon Genomics S.A., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases. Oryzon Genomics S.A. was founded in 2000 and is based in Barcelona, Spain. ORYZON GENOMICS operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 40 people.
Oryzon Genomics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Oryzon Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Oryzon Genomics' price varies over time.
3 ways to utilize Oryzon Genomics' volatility to invest better
Higher Oryzon Genomics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Oryzon Genomics SA stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Oryzon Genomics SA stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Oryzon Genomics SA investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Oryzon Genomics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Oryzon Genomics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Oryzon Genomics Investment Opportunity
Oryzon Genomics SA has a volatility of 1.5 and is 1.95 times more volatile than Dow Jones Industrial. 13 percent of all equities and portfolios are less risky than Oryzon Genomics. You can use Oryzon Genomics SA to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Oryzon Genomics to be traded at 1.4938 in 90 days.Average diversification
The correlation between Oryzon Genomics SA and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oryzon Genomics SA and DJI in the same portfolio, assuming nothing else is changed.
Oryzon Genomics Additional Risk Indicators
The analysis of Oryzon Genomics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Oryzon Genomics' investment and either accepting that risk or mitigating it. Along with some common measures of Oryzon Genomics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance | (0.09) | |||
Market Risk Adjusted Performance | (0.88) | |||
Mean Deviation | 1.04 | |||
Coefficient Of Variation | (824.80) | |||
Standard Deviation | 1.5 | |||
Variance | 2.26 | |||
Information Ratio | (0.21) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Oryzon Genomics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Oryzon Genomics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Oryzon Genomics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Oryzon Genomics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Oryzon Genomics SA.
Complementary Tools for Oryzon Stock analysis
When running Oryzon Genomics' price analysis, check to measure Oryzon Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oryzon Genomics is operating at the current time. Most of Oryzon Genomics' value examination focuses on studying past and present price action to predict the probability of Oryzon Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oryzon Genomics' price. Additionally, you may evaluate how the addition of Oryzon Genomics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |